Loading...
XNYS
SYK
Market cap139bUSD
Dec 05, Last price  
364.02USD
1D
-0.09%
1Q
-7.21%
Jan 2017
203.83%
Name

Stryker Corp

Chart & Performance

D1W1MN
XNYS:SYK chart
P/E
46.51
P/S
6.16
EPS
7.83
Div Yield, %
0.66%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
8.71%
Revenues
22.60b
+10.23%
4,871,500,0005,405,600,0006,000,500,0006,718,200,0006,723,100,0007,320,000,0008,307,000,0008,657,000,0009,021,000,0009,675,000,0009,946,000,00011,325,000,00012,444,000,00013,601,000,00014,884,000,00014,351,000,00017,108,000,00018,449,000,00020,498,000,00022,595,000,000
Net income
2.99b
-5.43%
675,200,000777,700,0001,017,400,0001,147,800,0001,107,400,0001,273,400,0001,345,000,0001,298,000,0001,006,000,000515,000,0001,439,000,0001,647,000,0001,020,000,0003,553,000,0002,083,000,0001,599,000,0001,994,000,0002,358,000,0003,165,000,0002,993,000,000
CFO
4.24b
+14.31%
863,800,000867,300,0001,028,300,0001,175,900,0001,460,700,0001,547,400,0001,434,000,0001,657,000,0001,886,000,0001,782,000,000899,000,0001,812,000,0001,559,000,0002,610,000,0002,191,000,0003,277,000,0003,263,000,0002,624,000,0003,711,000,0004,242,000,000
Dividend
Sep 30, 20240.8 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
IPO date
Mar 17, 1980
Employees
51,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT